Table 3.
Multiple logistic regression: predictors of non-appropriate VTE-prophylaxis prescription
| OR | 95% CI | p | |
|---|---|---|---|
| Diagnosis # | |||
| Neurological disorders | 1.814 | 0.808 - 4.072 | 0.149 |
| Gastrointestinal diseases | 0.188 | 0.052 - 0.681 | 0.011 |
| Electrolyte disturbances | 1.199 | 0.447 - 3.215 | 0.718 |
| Cancer/Chemotherapy | 2.851 | 0.819 - 9.930 | 0.100 |
| Cardiac diseases | 5.170 | 0.901 - 29.658 | 0.065 |
| Respiratory diseases | 0.838 | 0.238 - 2.951 | 0.783 |
| Others | 0.973 | 0.414 - 2.290 | 0.950 |
| Contraindications for pharmacologic prophylaxis | 0.696 | 0.315 - 1.538 | 0.371 |
| Surgery | 3.410 | 1.346 - 8.635 | 0.010 |
| Prophylaxis prescription upon admission | 0.419 | 0.199 - 0.881 | 0.022 |
| Obesity | 1.941 | 0.697 - 5.408 | 0.204 |
| Prophylaxis discontinuation during hospitalization | 1.531 | 0.605 - 3.873 | 0.369 |
| Enrollment during the second half of the study | 0.664 | 0.391 - 1.129 | 0.131 |
| Risk Group* | |||
| B | 5.317 | 2.369 -11.936 | 0.001 |
| C | 2.837 | 1.280 - 6.288 | 0.010 |
| E | 4.704 | 1.697 - 13.035 | 0.003 |
OR: Odds ratio
CI: Confidence interval
# Reference category: Infection
* Reference category: Group A